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Toxoplasma gondii has a complex two-host life-cycle between intermediate host and
definitive host. Understanding proteomic variations across the life-cycle stages of
T. gondii may improve the understanding of molecular adaption mechanism of T. gondii
across life-cycle stages, and should have implications for the development of new
treatment and prevention interventions against T. gondii infection. Here, we utilized
LC–MS/MS coupled with iTRAQ labeling technology to identify differentially expressed
proteins (DEPs) specific to tachyzoite (T), bradyzoites-containing cyst (C) and sporulated
oocyst (O) stages of the cyst-forming T. gondii Prugniuad (Pru) strain. A total of 6285
proteins were identified in the three developmental stages of T. gondii. Our analysis
also revealed 875, 656, and 538 DEPs in O vs. T, T vs. C, and C vs. O, respectively.
The up- and down-regulated proteins were analyzed by Gene Ontology enrichment,
KEGG pathway and STRING analyses. Some virulence-related factors and ribosomal
proteins exhibited distinct expression patterns across the life-cycle stages. The virulence
factors expressed in sporulated oocysts and the number of up-regulated virulence factors
in the cyst stage were about twice as many as in tachyzoites. Of the 79 ribosomal
proteins identified in T. gondii, the number of up-regulated ribosomal proteins was
33 and 46 in sporulated oocysts and cysts, respectively, compared with tachyzoites.
These results support the hypothesis that oocyst and cystic stages are able to adapt to
adverse environmental conditions and selection pressures induced by the host’s immune
response, respectively. These findings have important implications for understanding
of the developmental biology of T. gondii, which may facilitate the discovery of novel
therapeutic targets to better control toxoplasmosis.
Keywords: Toxoplasma gondii, life-cycle, mass spectrometry, proteomics, iTRAQ, differentially expressed protein
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INTRODUCTION
Toxoplasma gondii infection represents a significant global health
burden, with considerable social and economic implications. This
parasite can infect all vertebrate animals and humans (White
et al., 2014). Although most immuno-competent individuals do
not develop clinical disease, T. gondii infection in immuno-
compromised individuals, such as AIDS or cancer patients,
can cause severe encephalitis and retinochoroiditis (Suzuki
et al., 1996; Kijlstra and Jongert, 2008; Herrmann et al.,
2012). Also, congenital infection with T. gondii is a major
cause of spontaneous abortion, preterm labor, or significant
diseases in the survived neonate (Montoya and Liesenfeld,
2004). Current treatments are expensive and toxic (McLeod
et al., 2006); and together with the lack of a vaccine
makes the need for new therapeutic agents very urgent.
Development of new treatment and prevention approaches
including anti-T. gondii drugs and vaccines can be most
potent if targeted at specific life-cycle stages and/or specific
proteins expressed at these developmental stages. Therefore,
better understanding of the developmental biology and stage-
specific molecular determinants of the life-cycle stages is urgently
needed.
Toxoplasma gondii has a complex, two-host life-cycle that
involves both asexual (takes place in any vertebrate animal as an
intermediate host) and sexual (occurs only in the felid definitive
host) reproductive cycles (Blader et al., 2015). The sexual cycle
of T. gondii occurs exclusively in the enteroepithelial cells of the
intestine of the felid’s host (Behnke et al., 2014) and culminates
in the production of oocysts, which are adapted to survive
under adverse climatic conditions (Dubey, 2010). Toxoplasma
gondii oocysts are shed non-sporulated (non-infective) in cat
feces, and in a few days they undergo a sporulation process in
the environment and with appropriate climatic conditions they
mature to sporulated oocysts. In the intermediate host, T. gondii
undertakes asexual reproduction cycle, which follows ingestion
of sporulated oocysts or ingestion of tissue containing T. gondii
cysts full of bradyzoites (Dattoli et al., 2011). Asexual cycle
involves two different tissue stages produced in different phases
of the infection process and play different roles. These two stages
exist as a replicative tachyzoite stage (Hehl et al., 2015), which can
transform to slowly replicating bradyzoites within a tissue cyst,
which are commonly found in the central nervous system (Bohne
et al., 1999). Both of tachyzoite and bradyzoite are infective to
cats.
Advances in proteomic technologies have already contributed
to an increasing understanding of the protein expression in
T. gondii. For example, in 2002 the first proteome map
of T. gondii tachyzoite was constructed using 2-dimensional
Abbreviations: SPF, specific pathogen free; PBS, phosphate buffered saline; DEPs,
differentially expressed proteins; 2-DE, 2-dimensional electrophoresis; iTRAQ,
isobaric tags for relative and absolute quantification; MALDI-TOF-MS, matrix-
assisted laser-desorption/ionization time of flight mass spectrometry; 2D-DIGE,
two-dimensional fluorescence difference gel electrophoresis; FDR, false discovery
rate; GO, GeneOntology; KEGG, Kyoto Encyclopedia of Genes andGenomes; PPI,
Protein-protein interactions; CV, Coefficient of variation.
electrophoresis (2-DE) combined with matrix-assisted laser-
desorption/ionization time of flight mass spectrometry (MALDI-
TOF-MS) (Cohen et al., 2002). Zhou et al. employed two-
dimensional difference gel electrophoresis (2D-DIGE) coupled
with MALDI-TOF-MS to compare the differentially expressed
proteins of four different genotypes of T. gondii tachyzoites
(Zhou et al., 2014). Also, proteins expressed by oocysts and
sporozoites of T. gondii have been studied (Fritz et al., 2012;
Possenti et al., 2013). However, global protein expression patterns
across the developmental stages of T. gondii have yet to be
determined. In order to understand the functional differences
among different stages of T. gondii life-cycle it is important to
identify and quantify the protein’s content of these stages.
Comparative proteomic analysis requires the use of
exceptionally sensitive mass spectrometric approaches. In
this study, we utilized LC-MS/MS analysis coupled with isobaric
tags for relative and absolute quantification (iTRAQ) labeling
and SCX fractionation to identify and quantify differentially
expressed proteins of different stages of T. gondii life-cycle.
iTRAQ is a quantitative proteomic method that can generate
information on the abundance of hundreds of proteins at one
time. Also, it allows parallel biological or technical replicates to
be multiplexed (4-plex or 8-plex iTRAQ labeling) in one LC-
MS/MS experiment, thus overcomes the inter-assay variations
that occur in a single MS-based shotgun profiling experiment
(Wu et al., 2006; Pierce et al., 2008; Craft et al., 2013). Also, this
method has been successfully used to determine the differentially
expressed proteins of T. gondii oocysts during sporulation
(Zhou et al., 2016). The present study aimed to unravel the
set of proteins that are unique to three life-cycle stages of T.
gondii, namely oocyst, tachyzoite, and bradyzoites-containing
cyst using 8-plex iTRAQ labeling and LC-MS/MS. We identified
differentially expressed proteins, which are specific to the three
infective life-cycle stages of T. gondii.
MATERIALS AND METHODS
Ethics Approval
All protocols were reviewed and approved by the Animal
Research Ethics Committee of Lanzhou Veterinary Research
Institute, Chinese Academy of Agricultural Sciences. The
experiments were performed in a strict accordance with the
Animal Ethics Procedures and Guidelines of the People’s
Republic of China. All efforts were made to minimize suffering
of the animals.
Mice, Cats, and Parasite Strain
Six to eight week-old female BALB/c mice and 10 week-old
female kitten were obtained from Laboratory Animal Center of
Lanzhou Veterinary Research Institute. Type II Prugniuad (PRU)
strain of T. gondii was maintained in our laboratory by passaging
the cysts in mice as described previously (Zhou et al., 2016).
Preparation of Parasite Materials
Collection of Tachyzoites
Tachyzoites of Type II Prugniuad (PRU) strain were collected
using a previously described method (Zhou et al., 2011, 2014).
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Briefly, specific-pathogen free (SPF) mice were treated with
0.2mg of dexamethasone (DSMS) every other day for three times
and then inoculated orally with 100–150 cysts. Nine days after
infection the peritoneal cavity was rinsed with sterile phosphate-
buffered saline (PBS, 137mM NaCl, 2.7mM KCl, 10mM
Na2HPO4, 2mM KH2PO4) to harvest the tachyzoites. Then, the
peritoneal wash containing the tachyzoites was collected and
centrifuged for 15min at 1,680 g followed by two further washes
with PBS. After the final wash the supernatant was decanted and
the pellet was digested with 0.25% trypsin at 37◦C for 20min and
centrifuged for 15min at 1,680 g. The supernatant was removed
and the final protein pellet was suspended in 1 mL PBS and was
kept in an Eppendorf tube at−80◦C until analysis.
Isolation and Purification of Cysts
Mice were infected orally with 100–150 T. gondii cysts and were
humanely sacrificed 4 weeks later. Mice brains were collected
and grinded with a pestle and mortar. During grinding, 1ml of
PBS per mouse brain was added slowly as grinding proceeds.
The brain homogenate was layered on the top of Lymphocyte
Separation Medium (Solarbio, Beijing, China) in a plastic tube
followed by centrifugation at 2,290 g for 30 min. The parasite
cysts were harvested and kept at−80◦C until use.
Preparation of Sporulated Oocysts
Specific-pathogen-free kitten was infected with 200 cysts
recovered from mice brain and its feces was collected daily
to isolate oocysts using caesium chloride (CsCl) centrifugation
method as described previously (Staggs et al., 2009). Briefly, fecal
samples were mixed in water and filtered through 250µmmesh.
The filtrates were pelleted by centrifugation and the supernatant
was discarded. Following three washes in PBS, the supernatant
was discarded and the pellet was mixed with 5 volumes of sucrose
solution with 1.15 specific gravity. The supernatant containing
oocysts were collected, suspended in TE buffer (10mMTris-HCl,
1mM EDTA, pH = 8.0) and centrifuged using discontinuous
CsCl gradient method. Oocysts at the opaque-to-white layer
interface were collected and washed with 0.85% saline. Finally,
the oocyst pellet was suspended in PBS and maintained at 4◦C.
To induce sporulation, the oocyst’s suspension was centrifuged
and the pelleted oocysts were mixed with 2% H2SO4, and were
maintained in an aerobic condition at ambient temperature for 7
days. Then the oocyst’s suspension was washed with 0.85% saline,
and the mature/sporulated oocysts were mixed with 2% H2SO4
and stored at 4◦C until analysis.
Protein Extraction
Proteins were extracted from at least two biological repeats of
each of the life-cycle stages, namely tachyzoites (∼108), cysts
(∼107) and oocysts (∼107). Briefly, each biological sample was
homogenized with 5 volumes glass sand and lysed in 200 µl
radioimmunoprecipitation assay (RIPA) buffer (20mMTris-HCl
pH 7.5, 150mM sodium chloride, 2mM EDTA, 1% DOC, 1%
Triton X-100) containing phenylmethylsulfonyl fluoride (PMSF).
Then, samples were sonicated (2%, 1 s ON and 1 s OFF cycle,
5 times, 8 repeats) and the supernatant containing total soluble
proteins was collected after 20-min centrifugation at 13,400 g.
The concentration of the protein was determined by the protein
quantitative kit (QuantiProTM BCA Assay Kit, Sigma).
Protein Digestion and iTRAQ Labeling
For protein digestion, 100µg protein of each sample
was reduced, alkylated, and then precipitated by the
methanol/chloroform precipitation method. Firstly, 50 mM
Reducing Reagent (final concentration, 8-plex iTRAQ kit, AB
Sciex, USA) were added into each sample followed by incubation
at 60◦C for 1 hr. Then, the sample was mixed with 200 mM
Cysteine-Blocking Reagent (final concentration, 8-plex iTRAQ
kit, AB Sciex, USA) and held at ambient temperature for 10
min. Following rinsing the 10 KD ultrafiltration cartridge
with 70% ethanol and deionized water, the protein solution
was poured into ultrafiltration cartridge and centrifuged at
13,400 g for 20 min. Solution at the bottom of ultrafiltration
cartridge was discarded and the ultrafiltration cartridge was
centrifuged with 100µl 0.25M TEAB (triethyl ammonium
bicarbonate) three times at 13,400 g for 20 min. The protein
pellets were reconstituted in 50µl of 6 M urea/50 mM TEAB
with sonication (Possenti et al., 2013) and digested in 2% trypsin
overnight (Promega). Then, the digested peptides were dried
and reconstituted in 0.5 M TEAB. Then, peptides were labeled
according to the instructions of 8-plex iTRAQ kit (Applied
Biosystems/MDS Sciex, Foster City, CA). Label reagent mixed
with 150µl isopropyl alcohol was mixed with samples and
incubated for 2 hr at ambient temperature. The reaction was
terminated with deionized water and samples were thoroughly
mixed. Following vacuum centrifugation, dried samples were
preserved at −80◦C until use. Proteins of sporulated oocysts
were labeled with 115 and 116, whereas the proteins of the
cysts and tachyzoites were labeled with 117, 118, and 119, 121,
respectively.
SCX Fraction and LC-MS/MS Analysis
Strong cation exchange (SCX) fractionation chromatography was
performed using the high performance liquid chromatography
(HPLC) system (Phenomenex columns; Gemini-NX 3u C18
110A; 150∗2.00mM). The iTRAQ-labeled peptides were
separated by a linear gradient formed by mobile phase A (20mM
HCOONH4, pH 10) and mobile phase B (20mM HCOONH4,
80% ACN, pH 10). The flow of peptides elution was set to a
constant rate of 200µl/min. A total of 24 fractions were collected
by a linear gradient (1 collection every 1min, 100min) and
were acidified with trifluoroacetic acid (50%). The fractions were
vacuum-dried for further analysis with LC-MS. Fractions (96µg)
were dissolved in buffer A [0.1% formic acid, 2% acetonitrile
(ACN)] and pelleted at 13,447 g for 20min. The supernatant
was loaded onto analytical columns and was identified with an
online Q Exactive system (Thermal Scientific). Component of
mobile phase A and mobile phase B of LC-MS was formic acid
(0.1%) and 80% ACN containing 0.1% formic acid, respectively.
The flow rate of analytical columns was set at 350 nl/min and
the peptides were analyzed within 65min 3-step gradient (80%
ACN in 0.1% formic acid from 4 to 50% over 45min, 50 to 90%
over 5min and kept at 90% for 5min). The parameters of the
first grade MS included scan ranges from 350 to 1,800 m/z at
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a resolution of 70,000 with a maximum injection time of 40
ms. The second grade MS spectra were acquired in a resolution
of 17,500 with 60 ms maximum injection time and the 20 top
precursors for each MS cycle were selected.
Database Search and Bioinformatics
Analysis
The raw MS data was transformed into mascot generic
format (.mgf) files with Proteome DiscovererTM 1.4 and
the data file was used to query T. gondii ME49 strain
database (http://www.toxodb.org/common/downloads/release-
10.0/TgondiiME49/fasta/data/), which contains 8322 protein
sequences. The ProteinPilotTM Software 4.5 (AB SCIEX) was
used to further identify and quantity proteins. To filter the
results, we employed false discovery rate (FDR) of less than
0.01 for identification and the confidence level of 95% or
unused confidence score larger than 1.3 for quantification. For
differentially expressed proteins (DEPs), those with |log2 fold
change|>1 were deemed upregulated or downregulated proteins,
respectively.
Functional classification of the DEPs was performed
according to Gene Ontology (GO) annotation and
enrichment (http://www.geneontology.org) analysis. The
DEPs were classified into three categories, namely molecular
function, biological process and cellular component. The
Kyoto Encyclopedia of Genes and Genomes (KEGG)
(http://www.kegg.jp/kegg/) was used to predict molecular
function, biological processes and significant DEPs pathways.
Protein-protein interactions (PPI) were predicted in the
Search Tool of the Retrieval of Interaction Genes/Proteins
(STRING) database and the interaction network was illustrated
by Cytoscape software. The PPI whose combined score was>0.9
were subjected to further interaction network analysis.
RESULTS
Overview of Primary Data and Protein
Identification
iTRAQwas used to identify the proteomic differences among life-
cycle stages of T. gondii, namely sporulated oocyst, tachyzoite,
bradyzoites-containing cyst. Representative SCX chromatogram
of the results is shown in Figure S1. A total of 6,285 proteins
were identified from 53,335 peptides, which were matched with
76,534 spectra at a false discovery rate of 1%. Multiple proteins
were identified, among which, 1667, 1697, and 1791, proteins
were identified in O vs. T (oocysts vs. tachyzoites), T vs. C
(tachyzoites vs. cysts) and C vs. O (cysts vs. oocysts), respectively
after filtration (CV ≤ 0.5) (Tables S1–S3). Using 99% confidence
level (CV≤0.5), 1602, 1625, and 1719 proteins were identified
in O vs. T, T vs. C, and C vs. O, respectively (Tables S4–S6).
Compared with analysis using 95% confidence level, 65 proteins,
72 proteins and 72 proteins were lost in O vs. T, T vs. C, and C
vs. O. Repeatability analysis based on the Coefficient of variation
(CV) showed that 79.3, 81.8, and 90.7% proteins can be covered
in the total identified proteins in O vs. T, T vs. C, and C vs. O,
respectively, when the CV was less than 0.5 (Figure 1).
Protein Quantification and Hierarchical
Clustering Analysis
In brief, 875 proteins, 656 proteins, and 538 proteins were defined
as differentially expressed protein (DEPs) in O vs. T, T vs. C
and C vs. O, respectively (|log2 fold change|>1 and P < 0.05)
(Tables S7–S9). Among DEPs in each group, 801 proteins and 74
proteins were upregulated or downregulated in oocyst compared
with tachyzoite stage. There were 146 upregulated proteins and
510 downregulated proteins in T vs. C. Further, 180 proteins
and 358 proteins had higher or lower expression level in cyst
than in oocyst. Numbers of DEPs in different level are presented
in Figure 2. Results of the hierarchical clustering analysis of the
identified proteins are shown in Figure 3.
Gene Ontology Analysis of DEPs
The DEPs were subjected to functional classification by Gene
Ontology (GO) analysis. We identified 3371, 2846, and 1998 GO
terms in O vs. T, T vs. C and C vs. O, respectively. Among
these GO terms, there were 1708 molecular function terms, 874
biological process terms and 789 cellular component terms in O
vs. T. GO terms in T vs. C included 1392 molecular function
terms, 832 biological process terms, 622 cellular component
terms and GO terms in C vs. O included 1083 molecular function
terms, 634 biological process terms and 281 cellular component
terms. Those GO terms were classified and enriched in order
to investigate the properties of upregulated and downregulated
proteins in each group. The most 40 enriched GO terms in each
group and their destination to three main GO categories are
presented in Figure 4.
As is shown in Figure 4A, for O vs. T, the top five enriched
GO terms for upregulated proteins within molecular function
were ion binding, oxidoreductase activity, kinase activity,
peptidase activity and structural constituent of ribosome.
The top five enriched GO terms for downregulated proteins
were kinase activity, DNA binding, helicase activity, RNA
binding, and oxidoreductase activity. Translation, small
molecule metabolic process, catabolic process, cellular nitrogen
compound metabolic process and transport were the five top
terms for upregulated proteins under biological process. The
top five enriched GO terms for downregulated proteins
in biological process were cellular nitrogen compound
metabolic process, biosynthetic process, small molecule
metabolic process, cellular protein modification process,
and DNA metabolic process. The most abundant GO terms
for upregulated proteins under cellular component were
intracellular, followed by protein complex, cytoplasm, ribosome
and nucleus. Protein complex, nucleus, chromosome, cytoplasm
and intracellular were the five top terms for downregulated
proteins.
With regard to GO enrichment for upregulated proteins in
T vs. C, ion binding, biosynthetic process, extracellular region
were the most enriched terms in molecular function, biological
process and cellular component respectively. For downregulated
proteins, ion binding, structural constituent of ribosome, RNA
binding were the top three terms under molecular function
and translation, cellular nitrogen compound metabolic process,
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FIGURE 1 | Repeatability analysis based on Coefficient of Variation (CV) of O vs. T, T vs. C and C vs. O. The x-axis represents values of CV. The y-axis on the left
represents the number of proteins. The y-axis on the right represents the cumulative percentage of proteins. (A–C) represent repeatability analysis of O vs. T, T vs. C
and C vs. O, respectively. O, oocysts; T, tachyzoites; C, bradyzoites-containing cysts.
transport were the most three enriched terms under biological
process. The top five terms within cellular component included
intracellular, cytoplasm, protein complex, ribosome, nucleus
(Figure 4B).
Among molecular function terms in C vs. O, ion binding,
oxidoreductase activity, ligase activity, kinase activity and DNA
binding were the mostly prevalent terms for upregulated
proteins. The most five prominent terms for downregulated
proteins were ion binding, oxidoreductase activity, kinase
activity, peptidase activity, and lyase activity. Biosynthetic
process and small molecule metabolic process occupied top
one position in biological process for upregulated proteins and
downregulated proteins respectively. The mostly enrichment
terms within cellular component for upregulated proteins
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or downregulated proteins were cytoplasm and intracellular
respectively (Figure 4C).
KEGG Pathway Analysis of DEPs
To identify the biological pathways operating during T. gondii
development, we mapped the DEPs in each group to reference
pathways contained in the KEGG pathway database. Among
DEPs identified in each group, 401 DEPs, 654 DEPs, 536 DEPs
had a KEGG Orthology (KO) ID and could be mapped to
55 pathways, 55 pathways, 61 pathways in O vs. T, T vs. C,
and C vs. O, respectively. Of the 55 enriched pathways in
group O vs. T, 42 pathways were upregulated and no pathway
was downregulated. The top 5 enriched upregulated pathways
were metabolic pathways, biosynthesis of secondary metabolites,
biosynthesis of antibiotics, carbon metabolism, and ribosome
(Figure 5A).
There were 5 upregulated pathways and 13 downregulated
pathways in T vs. C. Ribosome, fatty acid metabolism,
biosynthesis of unsaturated fatty acids, alpha-Linolenic acid
metabolism, galactose metabolism were upregulated pathways
and the top 5 enriched downregulated pathways included
metabolic pathways, carbon metabolism, aminoacyl-tRNA
biosynthesis, RNA transport, and protein processing in
endoplasmic reticulum (Figure 5B).
In C vs. O, 2 and 25 pathways were up- and down-
regulated, respectively. The up-regulated pathways included
aminoacyl-tRNA biosynthesis, pyruvate metabolism and the
five most enriched downregulated pathways were metabolic
pathways, biosynthesis of secondary metabolites, biosynthesis of
antibiotics, carbon metabolism, and biosynthesis of amino acids
(Figure 5C).
Analysis of Virulence Factor Expression
To study the expression pattern of virulence factors across
the life-cycle stages of T. gondii, the expression levels of 23
virulence factors, which simultaneously appear in all groups were
analyzed. None of these virulence factors were downregulated
and 20 factors were upregulated in oocyst compared with
tachyzoite except RON4, PHIL1, and RON5 (Figure 6A). In
T vs. C, while five virulence factors (SPATR, PP2C, VP1,
ROP5, AMA1) were upregulated in tachyzoite vs. cyst, the
number of downregulated virulence factors was 10 (RON5,
ROP16, RON2, GRA4, MIC3, ROP2A, GRA1, GRA6, GRA7,
MIC6) (Figure 6B). The outcome of comparison between
C and O was similar to O vs. T. No virulence factor
exhibited higher expression level in cyst and 11 virulence
factors were upregulated in the oocysts (GRA7, ROM4, MIC3,
MIC6, PP2C, ROP18, VP1, AMA1, MIC2, SPATR, ROP5)
(Figure 6C).
Expression Pattern of Ribosomal Proteins
The differences of ribosomal protein expression among the
different life-cycle stages showed upregulation of 33 and 46
ribosomal proteins in oocyst and in cyst, compared to tachyzoite.
Six ribosomal proteins had higher expression level in cysts
compared with oocyst (Table 1).
FIGURE 2 | Distributions of differentially expressed proteins (DEPs) of O vs. T,
T vs. C and C vs. O in different level of differentiation. (A–C) represent
distributions of DEPs of O vs. T, T vs. C and C vs. O, respectively. The x-axis
indicates values of log2 fold changes. The y-axis indicates the number of
proteins. Red and green colors represent upregulated and downregulated
DEPs. O, oocysts; T, tachyzoites; C, bradyzoites-containing cysts.
String Analysis of Protein-Protein
Interactions for DEPs
The protein-protein interactions (PPI) whose combined score
was>0.9 were used to build network using Cytoscape tool in each
group. As shown in Figures 7, 8, there were 310 nodes and 1501
edges in the PPI network of O vs. T, and 273 nodes and 1769
edges in the PPI network of T vs. C. The PPI network of C vs. O
contained 152 nodes and 308 edges (Figure 9).
DISCUSSION
In order to understand the functional differences across the
different life-cycle stages of T. gondii, it is important to identify,
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FIGURE 3 | Hierarchical clustering of DEPs of O vs. T, T vs. C and C vs. O. Expression values were log2-transformed. TRP1 and TRP2 represent biological replicates
1 and 2. (A–C) represent hierarchical clustering of DEPs for O vs. T, T vs. C and C vs. O, respectively. O, oocysts; T, tachyzoites; C, bradyzoites-containing cysts.
quantify and compare the protein repertoire of each of these
life cycle forms. In the context of host-pathogen interaction,
such insights have the potential to reveal new mechanistic
determinants of T. gondii infectivity and adaptation. In this
study, we applied iTRAQ labeling coupled with LC-MS/MS
approach to profile and compare the proteome of T. gondii
oocysts, tachyzoites and bradyzoites-containing cysts. A total
of 6285 proteins were identified in the three developmental
stages of T. gondii. The comparative analysis identified significant
differences in the level of expressed proteins when comparing
oocysts to tachyzoites (875 proteins), tachyzoites to cysts (656
proteins) and cysts to oocysts (538 proteins). Based on GO and
KEGG analyses, ribosomal proteins and proteins involved in
macromolecule metabolism were the predominant groups.
A number of virulence-related factors and ribosomal proteins
exhibited distinct expression patterns across the life-cycle stages.
Some virulence factors can be upregulated during the sporulation
of oocysts (Wu et al., 2006). In our study, a number of proteins
with a virulence function have been identified. Compared with
oocysts, none of virulence factors was significantly overexpressed
in tachyzoite and cyst stages. By contrast, 23 and 11 virulence
factors were upregulated in oocyst compared with tachyzoites
and cysts, respectively. This indicates that oocysts expressed
more virulence factors compared to other stages of the life-
cycle of T. gondii. Interestingly, the number of upregulated
virulence factors was twice the number of downregulated factors
in cyst compared with tachyzoite. These findings seem consistent
with previous data, which reported that genes coding for β-
oxidation enzymes are not expressed in tachyzoites, but may be
active in oocysts (Possenti et al., 2013). Additionally, the dense
granule protein GRA1 (a specific protein that is known to be
expressed at the transformation from tachyzoites to bradyzoites)
was found down-regulated in tachyzoites compared to cysts in
our study. This finding is also consistent with pervious work,
which reported a progressive suppression in the expression of this
protein during the formation of bradyzoites-containing tissue
cysts (Cleary et al., 2002). GRA1 protein has been shown to be
up-regulated in sporulated oocysts as well (Tilley et al., 1997;
Possenti et al., 2013). The biological and clinical relevance of
these differences remain to be investigated using functional
assays.
Previous studies have shown that certain proteins might
be functional in certain life-cycle stages. For example, while
the homoserine kinase has been observed in the proteome of
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FIGURE 4 | GO enrichment analysis of DEPs of O vs. T, T vs. C and C vs. O. DEPs in each group were sorted into three categories. The x-axis means different GO
terms. The y-axis represents the number of proteins in the indicated categories. (A–C) represent GO enrichment analysis of DEPs for O vs. T, T vs. C and C vs. O,
respectively. O, oocysts; T, tachyzoites; C, bradyzoites-containing cysts.
oocysts (Possenti et al., 2013), genes encoding for homoserine
kinase (TGME49_216640) and other enzymes in the threonine
biosynthesis pathway, such as aspartokinase (TGME49_227090),
aspartate-semialdehyde dehydrogenase (TGME49_205420), and
threonine synthase (TGME49_220840), are known to be
expressed at low levels in the tachyzoite stage. In agreement
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FIGURE 5 | KEGG pathway analysis of DEPs of O vs. T, T vs. C and C vs. O. The x-axis represents different KEGG pathways. The y-axis represents the number of
proteins. (A–C) represent KEGG pathway analysis of DEPs of O vs. T, T vs. C and C vs. O, respectively. O, oocysts; T, tachyzoites; C, bradyzoites-containing cysts.
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FIGURE 6 | Expression profiles of differentially expressed (DE) virulence
factors of O vs. T, T vs. C, and C vs. O. Expression values were
log2-transformed and the expression levels were annotated with a gradient
color scheme. The horizontal axis represents the logogram of virulence factors.
The TRP1 and TRP2 in y-axis means biological replicate 1 and 2. (A–C)
represent expression profiles of DE virulence factors for O vs. T, T vs. C, and C
vs. O, respectively. O, oocysts; T, tachyzoites; C, bradyzoites-containing cysts.
with these studies our results based on comparing oocysts to
tachyzoites’ DEPs showed kinase activity amongst the top five
enriched GO terms for differentially regulated proteins within
molecular function. Our study also identified proteins with
greater abundance that were involved in biological process, such
as cellular nitrogen compound metabolic process, biosynthetic
TABLE 1 | Expression analysis of Toxoplasma gondii ribosomal proteins (TgRP).
TgRP O vs. T T vs. C C vs. O TgRP O vs. T T vs. C C vs. O
S2 — — — L10A ↑ ↓ —
S3 ↑ ↓ — L11 — — —
S3A — ↓ — L12 ↑ ↓ —
S4 ↑ ↓ — L13 ↑ ↓ —
S5 ↑ ↓ — L13A — ↓ —
S6 ↑ ↓ — L14 — — —
S7 ↑ ↓ — L15 ↑ ↓ —
S8 ↑ — L17 — ↓ —
S9 ↑ ↓ — L18 — — —
S10 ↑ — — L18A — — —
S11 — ↓ ↑ L19 ↑ ↓ —
S12 — — — L21 — ↓ —
S13 ↑ ↓ — L22 — — —
S14 ↑ — — L23 ↑ — —
S15 ↑ ↓ — L23A — ↓ —
S15A ↑ ↓ — L24 ↑ ↓ —
S16 ↑ ↓ — L26 ↑ ↓ —
S17 ↑ ↓ — L27 — ↓ —
S18 — — — L27A — — —
S19 — ↓ — L28 — — —
S20 — — — L29 — — —
S21 — ↓ ↑ L30 — ↓ —
S23 ↑ ↓ — L31 — — —
S24 — ↓ — L32 — ↓ —
S25 — — — L34 ↑ ↓ —
S26 ↑ ↓ — L35 — ↓ ↑
S27 — — — L35A — ↓ —
S27A — — — L36 — — —
S28 — — — L37 — — —
S29 — — — L37A — — —
S30 — — — L38 ↑ ↓ —
L3 ↑ ↓ — L39 — — —
L4 ↑ ↓ — L40 — — —
L5 ↑ ↓ — L41 — — —
L6 ↑ ↓ — L44 ↑ ↓ —
L7 ↑ ↓ ↑ SA — ↓ —
L7A — — ↑ P0 — ↓ —
L8 ↑ ↓ ↑ P1 — — —
L9 — ↓ — P2 — — —
L10 — — —
↑, upregulated; ↓, downregulated; —, non-significant changes.
O, oocysts; T, tachyzoites; C, bradyzoites-containing cysts.
process, small molecule metabolic process, cellular protein
modification process, and DNA metabolic process in the
tachyzoites compared to oocysts. This finding supports the higher
bioenergetics and metabolic need of T. gondii replicative forms
(tachyzoites), which rely heavily on glucose uptake and glycolysis
for generation of ATP and other intermediates required for
energy generation and replication (Al-Anouti et al., 2004).
The ribosome is the factory for protein synthesis that sustains
the development of biological organisms. It is assembled from
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FIGURE 7 | Protein-protein interaction networks of DEPs identified by iTRAQ of oocysts vs. tachyzoites. Proteins were indicated with nodes and interactions between
proteins were represented by edges. The node color indicates upregulated protein (red) or downregulated protein (green) and the size of node also presents
upregulation (large) or downregulation (small) of DEPs. The combined score were presented with edges colors.
both rRNA and ribosomal proteins (Meyuhas, 2000). The
synthesis and expression of ribosomal proteins is higher in
rapidly dividing cells and are regulated when the cell is under
stress or is stimulated by growth factors (Pearson and Haber,
1980; Ju andWarner, 1994; Zhang et al., 2013). Various coccidian
protozoan organisms are known to regulate the transcription
of ribosome biosynthesis in order to adapt to changes that
accompany stage transitions during their developmental life-
cycles (Meyuhas, 2000; Cleary et al., 2002). Toxoplasma gondii
contains 79 different ribosomal proteins, whose encoding genes
are randomly distributed across the T. gondii genome (Tilley
et al., 1997; Van Poppel et al., 2006). Seventy-one of the 79
ribosomal protein loci are distributed as single loci across the
genome, but 8 loci are unique in that they are paired at four
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FIGURE 8 | Protein-protein interaction networks of DEPs identified by iTRAQ of tachyzoites vs. bradyzoites-containing cysts. Proteins were indicated with nodes and
interactions between proteins were represented by edges. The node color indicates upregulated protein (red) or downregulated protein (green) and the size of node
also presents upregulation (large) or downregulation (small) of DEPs. The combined score were presented with edges colors.
locations in a head to head arrangement. In our study, oocysts
and cysts showed the highest expression of ribosomal proteins
compared to tachyzoites, indicating that these two stages have
more metabolic flexibility, which may contribute to their ability
to adapt to stress conditions. Oocysts are the environmental
infective forms of T. gondii, and can survive for extensive periods
of time outside the host (Torrey and Yolken, 2013). A previous
study indicated that there are stage-associated differences in
the expression of T. gondii ribosomal proteins (Schaap et al.,
2005). Intriguingly, Hutson et al. showed via the generation of
1rps13 strain-deficient in ribosomal protein S13 (RPS13) that
disruption of ribosomal proteins can lead to arrest of T. gondii
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FIGURE 9 | Protein-protein interaction networks of DEPs identified by iTRAQ of bradyzoites-containing cysts vs. oocysts. Proteins were indicated with nodes and
interactions between proteins were represented by edges. The node color indicates upregulated protein (red) or downregulated protein (green) and the size of node
also presents upregulation (large) or downregulation (small) of DEPs. The combined score were presented with edges colors.
cell cycle, resulting in dormant parasites which can persists
for several months in vitro, but without forming mature tissue
cysts (Hutson et al., 2010). The same authors also demonstrated
that immunization using the attenuated parasite 1rps13 strain
can protect mice against subsequent challenge with wildtype
T. gondii. However, it remains to be elucidated which of the
differentially expressed ribosomal proteins identified in our study
are essential for T. gondii ribosomes to function properly in the
respective stages of the life-cycle.
CONCLUSION
In the present study, we used iTRAQ-based LC-MS/MS
technique to compare the abundance of proteins in three life-
cycle forms of T. gondiii (oocyst, tachyzoite and bradyzoites-
containing cyst). Our results revealed differences in the protein
expression among the three life-cycle stages of this parasite,
providing new insight into the adaptation mechanisms of these
life-cycle forms to their habitats. These results lay the foundation
for the understanding of the developmental biology of T. gondii,
and should facilitate the discovery of novel therapeutic targets
and the development of novel stage-specific diagnostic assays to
augment available preventionmeasures to control toxoplasmosis.
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